medigraphic.com

2019, Number 6

<< Back Next >>

Rev Clin Esc Med 2019; 9 (6)

Peritonitis Bacteriana Espontánea

Vargas JJM, Salazar AMN

Language: Spanish
References: 28
Page: 31-36
PDF size: 436.32 Kb.


ABSTRACT

Spontaneous bacterial peritonitis is a common cause of infection in cirrhotic patients. It is associated with high mortality and requires invasive procedures for diagnosis, given the vagueness of its clinic. It presents a wide differential diagnosis. Management is based in empirical antibiotic therapy of broad spectrum, which needs to be adjusted according to cultures. Knowledge of local epidemiology is an indispensable tool to guide antibiotic treatment and reduce adverse results.


REFERENCES

  1. Conn HO. Spontaneous peritonitis and bacteremia in Laennec`s cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome. Ann Intern Med. 1964; 60:568-580.

  2. Barreales M Fernández I. Spontaneous bacterial peritonitis. Rev Esp Enferm Dig. 2011; 103:255-264.

  3. Stojan JN Lukela MD. Spontaneous bacterial peritonitis. Hospital Medicine Clinics. 2014; 3(3):350-361.

  4. Weist R et al. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012; 61:297-310.

  5. Salas R. Peritonitis bacteriana espontánea en pacientes cirróticos. Revista Médica de Costa Rica.1993; 552:15-19.

  6. Rimola A García-Tsao G Navasa M. et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000; 32:142-153.

  7. Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrosis. Hepatology. 2013; 57(4):1651-1653.

  8. Runyon BA. Bacterial infections in patients with cirrosis. J Hepatol. 1993; 18(3):271-272.

  9. Rimola A Soto R Bory F Arroyo V Piera C Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984; 4(1):53-58.

  10. Such J Runyon A. Spontaneous bacterial peritonitis. Clin Infect Dis. 1998; 27:669-676.

  11. Scarpellini E Valenza V Gabrielle M et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol. 2010; 105(2):323-327.

  12. Madrid A Cumsille F Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci. 1997; 42(4):738-742.

  13. Runyon BA Canawati HN Akriviadis EA. Optimization of ascitic fluid culture tech- nique. Gastroenterology. 1988; 95:1351-1355.

  14. Andreu M Sola R Sitges-Serra A et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology. 1993; 104:1133-1138.

  15. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 1986; 91:1343-1346.

  16. Min YW Lim KS Gwak GY et al. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study. Aliment Pharmacol Ther. 2014; 40(6):695-704.

  17. Goel GA Deshpande A López, R, et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol. 2012; 10(4):422-427.

  18. Runyon BA. Momomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990; 12:710-715.

  19. Runyon BA Antillon MR Akriviadis EA McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol. 1990; 12:2811-2812.

  20. Akriviadis EA Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990; 98(1):127-133.

  21. Runyon BA Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology. 1984; 4(3):447-450.

  22. Soriano G Castellote J Alvarez C. et al. Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol. 2010; 52(1):39-44.

  23. Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990; 12(4):710-715.

  24. Pelletier G Lesur G Ink O et al. Asymptomatic bacterascites: is it spontaneous bacterial peritonitis? Hepatology. 1991; 14(1):112-115.

  25. Karvellas C Abraldes J Arabi Y Kumar A. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment Pharmacol Ther. 2015; 41: 747–757.

  26. Mazer L Tapper E Piatkowski G Lai M. The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis – a retrospective cohort study examining the effect of ceftriaxone dosing. F1000Research. 2014; 3(57): 1-11.

  27. Follo A Llovet JM Navasa M et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology. 1994; 20:1495-1501.

  28. Sort P Navasa M Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999; 341:403-409.




2020     |     www.medigraphic.com